An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)
Clinical trial NCT07105254 · RECRUITING
Trial details
- NCT number
- NCT07105254
- Sponsor
- Derm Texas, PLLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-05-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.